<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Int Braz J Urol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Int Braz J Urol</journal-id>
      <journal-id journal-id-type="publisher-id">ibju</journal-id>
      <journal-title-group>
        <journal-title>International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1677-5538</issn>
      <issn pub-type="epub">1677-6119</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Urologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26401879</article-id>
      <article-id pub-id-type="pmc">4757015</article-id>
      <article-id pub-id-type="publisher-id">S1677-5538.IBJU.2014.0614</article-id>
      <article-id pub-id-type="doi">10.1590/S1677-5538.IBJU.2014.0614</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Video Section</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Robotic Salvage Lymph Node Dissection After Radical Prostatectomy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Torricelli</surname>
            <given-names>Fabio C. M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cividanes</surname>
            <given-names>Arnaldo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guglielmetti</surname>
            <given-names>Giuliano B.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Coelho</surname>
            <given-names>Rafael F.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Hospital das Cl&#xED;nicas da Faculdade de Medicina da Universidade de S&#xE3;o Paulo, SP, Brasil</aff>
        <aff id="aff2"><label>2</label>Hospital 9 de Julho, SP. Brasil</aff>
        <aff id="aff3"><label>3</label>Instituto do C&#xE2;ncer do Estado de S&#xE3;o Paulo (ICESP), SP, Brasil</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1"><bold>Correspondence address:</bold> F&#xE1;bio C&#xE9;sar Miranda Torricelli, MD, Av. Vereador Jos&#xE9; Diniz, 3300 / 208, S&#xE3;o Paulo, SP, 04604-006, Brazil. Telephone: <phone>+55 11 5533-4900</phone> E-mail: <email>fabio_torri@yahoo.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Aug</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Aug</season>
        <year>2015</year>
      </pub-date>
      <volume>41</volume>
      <issue>4</issue>
      <fpage>819</fpage>
      <lpage>820</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>11</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>6</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>ABSTRACT</title>
        <sec>
          <title>Introduction and objective:</title>
          <p>Radical prostatectomy is a first-line treatment for localized prostate cancer. However, in some cases, biochemical recurrence associated with imaging-detected nodal metastases may happen. Herein, we aim to present the surgical technique for salvage lymph node dissection after radical prostatectomy.</p>
        </sec>
        <sec>
          <title>Materials and Methods:</title>
          <p>A 70 year-old asymptomatic man presented with a prostate-specific antigen (PSA) of 7.45ng/ mL. Digital rectal examination was normal and trans-rectal prostate biopsy revealed a prostate adenocarcinoma Gleason 7 (3+4). Pre-operative computed tomography scan and bone scintigraphy showed no metastatic disease. In other service, the patient underwent a robotic-assisted radical prostatectomy plus obturador lymphadenectomy. Pathologic examination showed a pT3aN0 tumor. After 6 months of follow-up, serum PSA was 1.45ng/mL. Further investigation with 11C&#x2013;Choline PET/CT revealed only a 2-cm lymph node close to the left internal iliac artery. The patient was counseled for salvage lymph node dissection.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>Salvage lymph node dissection was uneventfully performed. Operative time was 1.5 hour, blood loss was minimal, and there were no intra- or postoperative complications. The patient was discharged from hospital in the 1st postoperative day. After 12 months of follow-up, his PSA was undetectable with no other adjuvant therapy.</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p>Robotic salvage pelvic lymph node dissection is an effective option for treatment of patients with biochemical recurrence after radical prostatectomy and only pelvic lymph node metastasis detected by C11-Choline PET/CT.</p>
        </sec>
      </abstract>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="3"/>
        <page-count count="2"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>ARTICLE INFO</title>
      <p>
<bold>ARTICLE INFO Available at:</bold>
<ext-link ext-link-type="uri" xlink:href="http://www.brazjurol.com.br/videos/july_august_2015/Torricelli_819_820video.htm"><bold>www.brazjurol.com.br/videos/july_august_2015/Torricelli_819_820video.htm</bold></ext-link>
</p>
      <p>
<bold>Int Braz J Urol. 2015; 41 (Video #7): 819-20</bold>
</p>
    </sec>
  </body>
  <sub-article id="Len" article-type="letter">
    <front-stub>
      <title-group>
        <article-title>EDITORIAL COMMENT</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Patel</surname>
            <given-names>Vipul</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mouraviev</surname>
            <given-names>Vladimir</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff4"/>
        </contrib>
        <aff id="aff4">Director of Urologic Oncology, Florida Hospital Cancer Institute, FL, USA. E-mail: <email>vipul.patel.md@flhosp.org</email></aff>
      </contrib-group>
    </front-stub>
    <body>
      <p>To date, an implementation of novel imaging techniques, such as PSMA or 11C-choline PET fused with CT or MRI, and diffusion-weighted MRI imaging (DWI), seem to significantly improve restaging of lymph node (LN) status after radical prostatectomy. From physician and patient prospects, it is outmost of importance to accurately detect the solitary LNs considering them as a final local resort of residual cancer disease. From this point, the precise preoperative mapping of potential targets can be a prerequisite for successful salvage robotic-assisted radical prostatectomy (sRARP). The recent data suggested that sLND can delay clinical progression and postpone hormonal therapy in almost one-third of the patients, although the majority of them will have biochemical failure (<xref rid="B1" ref-type="bibr">1</xref>).</p>
      <p>The presented videocase demonstrated that 11C-choline PET/CT scan may be useful as a reliable and promising tool for restaging of LN status in patients with biochemical recurrence of disease after RARP. However, more evidence-based data are needed to prove further validation of accuracy of this scan especially with low PSA threshold (less than 0.5-1.0ng/mL). Furthermore, the contemporary literature data and our initial clinical experience show a value of other radiopharmaceutical agent such as PSMA PET/CT scan as even more precise diagnostic modality. Otherwise, new data with DW-MRI use also seem to have favorable performance characteristics as well. For instance, Elbert et al. (<xref rid="B3" ref-type="bibr">3</xref>) examined the results on 29 patients with DW-MRI using quantitative parameter such as ADC (apparent diffusion coefficient) cut-off of 1.30x10-3 reporting a sensitivity, specificity and discrimination accuracy of this threshold to detect LN involvement as of 86%, 85% and 86%, respectively.</p>
      <p>Finally, image-guided sLND can be considered as a feasible and useful treatment option in patients with clinical LN failure after primary defnitive treatment such RARP.</p>
      <sig-block>
        <sig>
          <italic>Vipul Patel, MD and Vladimir Mouraviev, MD</italic>
          <break/>
          <italic>Director of Urologic Oncology</italic>
          <break/>
          <italic>Florida Hospital Cancer Institute, FL, USA</italic>
          <break/>
          <italic>E-mail: vipul.patel.md@flhosp.org</italic>
        </sig>
      </sig-block>
    </body>
    <back>
      <ref-list>
        <title>REFERENCES</title>
        <ref id="B1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Abdollah</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Briganti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montorsi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stenzl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stief</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tombal</surname>
                <given-names>B</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy</article-title>
            <source>Eur Urol</source>
            <year>2015</year>
            <volume>67</volume>
            <fpage>839</fpage>
            <lpage>849</lpage>
            <pub-id pub-id-type="pmid">24698524</pub-id>
          </element-citation>
        </ref>
        <ref id="B2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Kabasakal</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Demirci</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ocak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akyel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nematyazar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aygun</surname>
                <given-names>A</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging</article-title>
            <source>Nucl Med Commun</source>
            <year>2015</year>
            <volume>36</volume>
            <fpage>582</fpage>
            <lpage>587</lpage>
            <pub-id pub-id-type="pmid">25738559</pub-id>
          </element-citation>
        </ref>
        <ref id="B3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Eiber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Holzapfel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tauber</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ganter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Weirich</surname>
                <given-names>G</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging</article-title>
            <source>Invest Radiol</source>
            <year>2010</year>
            <volume>45</volume>
            <fpage>15</fpage>
            <lpage>23</lpage>
            <pub-id pub-id-type="pmid">19996762</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </sub-article>
</article>
</pmc-articleset>
